Please assess the completion status of the following clinical trial:

Trial Title: TTA in Treatment of Diabetes and Dyslipidemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* type 2 diabetes mellitus with HbA1c 8.0-12.0%,~* fasting S-triacylglycerol 2.0-10.0 mmol/L,~* body mass index 25-40 kg/m2 and/or waist/hip ratio \> 0.90.~Exclusion Criteria:~* fasting total cholesterol \>10 mmol/L,~* blood pressure 170/110 mmHg~* other significant disease~* Use of any corticosteroid, anticoagulant or lipid-lowering drug 2 weeks prior to inclusion.

- Gender: MALE
- Minimum Age: 30 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Single group (Type: ACTIVE_COMPARATOR): Single group all treated similarly, outcome evaluated as changes within individuals during intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).